Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferasirox versus desferoxamine for iron overload after stem cell transplantation
ISRCTN52984371Phase 3Completed
- Sponsor
- Instituto Aragonés de Ciencias de la Salud
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of deferasirox and deferoxamine in iron overload and hemosiderosis (2 arms), sponsored by Instituto Aragonés de Ciencias de la Salud. Primary endpoint: Serum ferritin response. Started Mar 2011; status: completed.
02
Drugs
deferasiroxdeferoxamine
03
Conditions
iron overloadhemosiderosis
Beyond the preview
Go deeper on ISRCTN52984371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN52984371.